Cancer Research Solutions India
Complete portfolio for Oncology research – Mumbai based distribution
Cancer research is a rapidly evolving field focused on understanding the molecular and cellular mechanisms driving tumour initiation, progression, and metastasis. Advances in areas such as genomics, immunology, and targeted therapies have significantly improved our ability to diagnose, monitor, and treat cancer.
This section brings together a comprehensive range of tools and technologies to support researchers across the entire workflow—from basic tumour biology studies to advanced therapeutic development, including cell and gene therapies.
Tumour biology focuses on understanding the molecular and cellular mechanisms that drive cancer initiation, progression, and metastasis. This area encompasses the study of oncogenic signaling pathways, tumor heterogeneity, cell proliferation, and interactions within the tumor microenvironment.
Supported by a diverse range of advanced in vitro models and functional platforms, tumour biology enables detailed investigation of cancer cell behavior and pathway dynamics. At Krishgen Biosystems, we offer a comprehensive range of tools including cancer cell models, gene editing systems, biomarkers, and functional assays to support oncology research and drug discovery.
Tumour Cell Lines
Tumour cell lines are well-characterized in vitro models derived from human and animal cancers, widely used to study oncogenic processes, signaling pathways, and therapeutic responses. These systems provide a controlled and reproducible platform for investigating cell proliferation, metastasis, drug sensitivity, and resistance mechanisms across diverse cancer types.
Available in both adherent and suspension formats, tumour cell lines support a broad range of applications including high-throughput screening, gene expression analysis, and functional assays. With authenticated, contamination-free profiles and extensive characterization data, these models are essential for robust and translational oncology research.
Explore Products:
- Standard tumour cell lines- Abmgood
- Standard tumour cell lines -Accegen
- Standard tumour cell lines – Addexbio
- Standard tumour cell lines- Cell biologics
- Drug-Resistant Cell Lines- CTDS
CRISPR & Gene Editing Models
CRISPR and gene editing models provide precise and efficient tools for targeted genome modification, enabling functional interrogation of oncogenes, tumor suppressors, and regulatory pathways in cancer. Technologies such as CRISPR/Cas9, base editing, and RNA-guided systems allow for gene knockout, knock-in, and transcriptional modulation with high specificity.
These engineered models support in-depth studies of gene function, pathway validation, and disease modeling across diverse cancer systems. Designed for both in vitro and in vivo applications, gene editing platforms are integral to target discovery, mechanism-of-action studies, and the development of next-generation oncology therapeutics.
Explore Products:
Functional Assays
Functional assays provide quantitative and real-time evaluation of cellular responses, enabling detailed analysis of cancer cell behavior under defined experimental conditions. These assays measure key endpoints such as proliferation, apoptosis, migration, invasion, and drug sensitivity, offering critical insights into oncogenic mechanisms and pathway activity.
Utilizing optimized cell-based platforms and high-throughput compatible systems, functional assays support target validation, mechanism-of-action studies, and therapeutic screening. Designed for reproducibility and scalability, they are essential tools for both exploratory and translational oncology research.
Through our network of globally recognized partner companies, we offer access to a comprehensive range of validated functional assay platforms and reagents tailored for advanced oncology applications.
Explore Products:
Stable / Immortalized Cell Lines
Stable and immortalized cell lines are genetically defined systems engineered or selected for sustained proliferation and long-term expression of target genes. These models provide a consistent and reproducible platform for studying oncogenic pathways, gene function, and cellular responses under controlled conditions.
Widely utilized in target validation, drug screening, and protein expression studies, stable cell lines enable reduced experimental variability and scalable workflows. With well-characterized phenotypes and stable integration profiles, they are essential tools for robust in vitro modeling and translational oncology research.
Through our network of globally recognized partner companies, we provide access to high-quality, authenticated stable and immortalized cell line models to support advanced oncology research and development.
Explore Products:
With a focus on elucidating and modulating the complex interactions between tumor cells and the immune system to enable targeted anticancer responses, this field encompasses immune checkpoint regulation, tumor immune evasion mechanisms, and the development of immunotherapeutic strategies such as checkpoint inhibitors, CAR-T cells, and cancer vaccines.
At Krishgen Biosystems, we collaborate with leading global partners to provide a comprehensive portfolio of validated reagents, antibodies, and assay platforms for immune profiling, pathway analysis, and translational research. Explore our partner companies below to access specialized solutions across key immuno-oncology applications, including cancer biomarkers, proteins and antibodies, and immune assay systems.
Cancer Biomarkers proteins and antibodies
Cancer biomarkers, along with high-quality proteins and antibodies, are critical for the detection, characterization, and monitoring of tumor progression and therapeutic response. These include validated targets such as cytokines, growth factors, immune checkpoint proteins, and oncogenic markers that enable precise molecular profiling of cancer and the tumor microenvironment.
Through strategic collaborations with globally recognized manufacturers, a comprehensive portfolio of recombinant proteins, monoclonal and polyclonal antibodies, and biomarker panels is available to support applications such as ELISA, Western blotting, flow cytometry, and immunohistochemistry, Immunofluorescence, ensuring high specificity, sensitivity, and reproducibility across research and translational workflows.
Explore Products:
Cell and gene therapy in oncology leverages advanced genome engineering and cell-based platforms to enable precise, mechanism-driven therapeutic strategies. This includes technologies such as viral and non-viral gene delivery systems, CRISPR/Cas-mediated genome editing, and adoptive cell therapies including CAR-T and TCR-engineered cells.
At Krishgen Biosystems, we partner with leading global manufacturers to provide high-quality vectors, gene editing tools, and cell-based systems that support target validation, functional studies, and translational workflows. Explore our partner companies below to access specialized solutions for cutting-edge cell and gene therapy research.
Explore products:
Oncology drug development integrates target identification, high-throughput screening, and mechanism-of-action studies to advance novel anticancer therapeutics from discovery through preclinical validation. This includes small molecules, biologics, and targeted agents designed to modulate oncogenic pathways, tumor microenvironment dynamics, and resistance mechanisms.
At Krishgen Biosystems, we collaborate with globally recognized technology providers to offer a comprehensive portfolio of validated reagents, assay platforms, and screening tools that support every stage of the drug development pipeline. Explore our partner companies below to access specialized solutions tailored for oncology research and translational applications.
Explore products:
- Sinobiologicals
- Biochain
- Krishgen:
Biomarker assays are critical for the quantitative detection and validation of molecular signatures associated with cancer initiation, progression, and therapeutic response. These assays enable precise measurement of proteins, nucleic acids, and metabolites, supporting patient stratification, target validation, and pharmacodynamic studies.
Utilizing robust platforms such as ELISA, multiplex immunoassays, and cell-based detection systems, biomarker assays provide high sensitivity, specificity, and reproducibility across diverse sample types. Designed for both discovery and translational workflows, these assays play a pivotal role in advancing precision oncology and accelerating data-driven therapeutic development.
Explore products:
Product Type
Tissue and toxicology models provide physiologically relevant systems to evaluate drug efficacy, safety, and off-target effects in oncology research. These models include 3D cultures, organotypic systems, and primary tissue-derived platforms that more accurately recapitulate the tumor microenvironment and tissue architecture compared to conventional 2D systems.
Designed to support predictive toxicology and translational studies, these platforms enable assessment of cytotoxicity, tissue-specific responses, and compound-induced stress or damage. With enhanced biological relevance and scalability, tissue and tox models are critical for preclinical evaluation, safety profiling, and de-risking of oncology drug candidates.
Explore products:
| Principal | Model Type | Key Offerings | Applications | Product Link |
|---|---|---|---|---|
| BioChain | Disease Models, Tissue Samples | Human tissue-derived disease models, biospecimens | Translational Research, Biomarker Discovery | View |
| Episkin | 3D Tissue Models | Reconstructed human epidermis models | Toxicology Testing, Skin Irritation Studies | View |
| Epithelix | Organotypic 3D Models | Airway epithelial tissues, respiratory models | Respiratory Toxicology, Drug Testing | View |
| ReadyCell | Cell-based Tox Kits | Caco-2 permeability kits, ready-to-use assays | ADME, Drug Transport, Toxicity Screening | View |
ELISA and assay kits provide robust, quantitative platforms for the detection and analysis of key biomarkers involved in cancer biology. These include cytokines, growth factors, signaling proteins, and other disease-relevant targets, enabling precise measurement across a wide range of sample types.
Designed for high sensitivity, specificity, and reproducibility, these kits support applications such as biomarker validation, pathway analysis, and pharmacodynamic studies. With standardized protocols and optimized reagents, ELISA and assay platforms streamline workflows for both high-throughput screening and routine oncology research applications.
Explore products:
| Principal | Assay Type | Key Offerings | Applications | Product Link |
|---|---|---|---|---|
| Krishgen Biosystems | ELISA Kits | Human Cytokine ELISA Kits, Cancer Biomarkers | Oncology Research, Diagnostics | View |
| Elabscience | ELISA Kits | Cancer Biomarker ELISA Kits, Tag & Cell Marker Kits | Cancer Research, Cell Biology | View |
| Elabscience | ELISA Kits | Tag Proteins, Cell Surface Marker ELISA Kits | Protein Expression Studies | View |
| Arbor Assays | Assay Kits | Cell Signaling Assays, cAMP/cGMP Kits | Signal Transduction, Pharmacology | View |
| Sino Biological | ELISA Kits | Cytokine ELISA Kits, Cancer-related Targets | Immunology, Oncology | View |
| AAT Bioquest | Biochemical Assays | Cell-based Assays, Fluorescence-based Kits | Drug Discovery, Cell Analysis | View |
| Cayman Chemical | ELISA & Multiplex Assays | Inflammation Kits, Cancer Pathway Assays | Oncology, Metabolism | View |
| Assaypro | ELISA Kits | Cancer-associated Biomarker Kits | Cancer Diagnostics, Research | View |
| ScienCell | Cell-based Assays | Functional Cell-based Assay Kits | Cell Signaling, Functional Studies | View |
Biomarker panels enable the simultaneous detection and quantification of multiple cancer-associated targets, providing a comprehensive view of disease biology and therapeutic response. These multiplexed systems are designed to analyze cytokines, growth factors, signaling molecules, and other clinically relevant biomarkers within a single experiment.
Utilizing advanced assay platforms such as multiplex immunoassays and bead-based systems, biomarker panels offer high sensitivity, reduced sample volume requirements, and improved throughput. They are widely used in pathway profiling, immune monitoring, and translational studies, supporting data-driven decision-making in oncology research and drug development.
Explore products:
- Krishgen (Multiplex ELISA): Coming soon…..
| Principal | Technology Platform | Key Offerings | Applications | Product Link |
|---|---|---|---|---|
| Sino Biological | ELISpot, Multiplex Immunoassays | Cytokine ELISpot Kits, Immune Response Panels | Immune Monitoring, Vaccine Research, Oncology | View |
| Cayman Chemical | Multiplex Assays, Bead-Based Systems | Inflammation Panels, Lipid Mediator Panels | Inflammation, Cancer Pathways, Metabolism | View |
Cell models serve as foundational platforms for investigating cancer biology, enabling controlled analysis of disease-relevant cellular processes and therapeutic responses. These systems include primary cells, tumor-derived lines, and genetically engineered models designed to reflect specific molecular and phenotypic characteristics of cancer.
They are widely applied in target discovery, pathway interrogation, drug screening, and mechanistic studies, offering flexibility across a range of experimental workflows. With high reproducibility and compatibility with advanced assay technologies, cell models support both exploratory and translational oncology research.
Through our network of globally recognized partner companies, we provide access to a diverse selection of validated cell-based systems to meet the complex demands of modern cancer research.
Explore Products:
| Principal | Model Type | Key Offerings | Applications | Product Link |
|---|---|---|---|---|
| abm | Tumor Cell Lines | Human cancer cell lines, engineered variants | Drug Screening, Target Validation | View |
| AddexBio | Tumor Cell Lines | Rare & specialty cancer cell lines | Disease Modeling | View |
| Cell Biologics | Primary Cells | Human tumour cells | Cell Biology, Translational Research | View |
| Cell Tech Discovery | Drug-Resistant Cell Lines | Chemoresistant cancer models | Drug Resistance Studies | View |
| ScienCell | Primary Cells & Stem Cells | Human primary cells, stem cell-derived models | Regenerative Medicine, Cancer Biology | View |
Explore Products:
| Principal | Product Categories | Key Products Offered | Applications | Product Link |
|---|---|---|---|---|
| Sino Biological | Recombinant Proteins, Antibodies | Cytokines, Growth Factors, Viral Proteins (SARS-CoV-2), Monoclonal Antibodies | Vaccine Research, Virology, Immunology | View |
| Bioss | Primary & Secondary Antibodies | IHC Antibodies, WB Antibodies, Fluorescent Antibodies | Cancer Research, Cell Biology | View |
| Santa Cruz Biotechnology | Antibodies, siRNA | Signal Pathway Antibodies, Transcription Factor Antibodies | Oncology, Molecular Biology | View |
| Abnova | Monoclonal Antibodies, Proteins | Tagged Proteins, Kinase Proteins, Antibody Pairs | Functional Assays, Diagnostics | View |
| Elabscience | Recombinant Proteins, Antibodies | Cytokines, Enzymes, Polyclonal Antibodies | Immunology, Inflammation | View |
| Chondrex | Proteins, Antibodies | Collagen Proteins, Autoimmune Research Antibodies | Arthritis, Autoimmunity | View |
| Cayman Chemical | Proteins, Enzymes, Antibodies | Metabolic Enzymes, Lipid-related Proteins | Metabolism, Inflammation | View |
| ScienCell | Growth Factors, Cytokines | Cell Culture Supplements, Recombinant Growth Factors | Stem Cells, Cell Culture | View |
| Antibody System | Custom Antibodies, | Monoclonal & Polyclonal | Therapeutics, Research | View View |